Holdings

Ishara Investments LP

As of Sep 30, 2026, Ishara Investments LP reported 36 positions worth US$114M. Largest: Travere Therapeutics, Inc., Cytokinetics, Incorporated and BridgeBio Pharma, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Travere Therapeutics, Inc.145KUS$8.54M+63,000Sep 30, 2026
Cytokinetics, Incorporated128KUS$8.44M+95,200Sep 30, 2026
BridgeBio Pharma, Inc.100KUS$6.58M+42,600Sep 30, 2026
ACADIA Pharmaceuticals Inc.320KUS$6.45M−90,000Sep 30, 2026
Tarsus Pharmaceuticals, Inc.70,000US$5.5MnewSep 30, 2026
PTC Therapeutics, Inc.80,000US$5.18MnewSep 30, 2026
Praxis Precision Medicines, Inc.17,000US$4.95M−5,550Sep 30, 2026
Vera Therapeutics, Inc.150KUS$4.84M+140KSep 30, 2026
Arcutis Biotherapeutics, Inc.180KUS$4.76MnewSep 30, 2026
Annexon, Inc.1.12MUS$4.74M+300KSep 30, 2026